The future of TMS in neonatal screening looks promising. Advances in analytical techniques and data analysis are likely to enhance the capabilities of TMS, making it even more robust and accessible. Integration with genetic screening and other omics technologies could provide a more comprehensive understanding of neonatal health, leading to earlier and more precise interventions.
